Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value per share ALIM The Nasdaq Stock Market LLC (Nasdaq Global Market) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 19 ...

Alimera Sciences, Inc. (NASDAQ:ALIM) Q2 2019 Earnings Conference Call July 30, 2019 9:00 AM ET Company Participants Scott Gordon - President of Core IR Rick Eiswirth - President & CEO Phil Jones - CFO Conference Call Participants Alex Nowak - Craig Hallum Capital Group Andrew D'Silva - B. Riley, FBR François Brisebois - Laidlaw Jim Molloy - Alliance Global Partners Yi Chen - H.C. Wainwright Operator Ladies and gentlemen, thank you for standing by. Good morning and welcome to the Alimera Sciences Second Quar ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-34703 Alimera Sciences, Inc. (Exact name of registrant as specified in its charter) Delaware 20-0028718 (State ...

Alimera Sciences, Inc. (NASDAQ:ALIM) Q1 2019 Earnings Conference Call April 30, 2019 9:00 AM ET Company Participants Scott Gordon - President of Core IR Rick Eiswirth - President and Chief Executive Officer Phil Jones - Chief Financial Officer Conference Call Participants Andrew D'Silva - B. Riley James Molloy - Alliance Global Partners François Brisebois - Laidlaw Yi Chen - H.C. Wainwright Operator Ladies and gentlemen, thank you for standing by. Good morning, and welcome to the Alimera Sciences First Quar ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-34703 | --- | --- | |----------------------------------------------------------------------------|---------------- ...

Alimera Sciences, Inc. (NASDAQ:ALIM) Q4 2018 Earnings Conference Call February 19, 2019 9:00 AM ET Company Participants Jacob Goldberger - Investor Relations, Analyst at CG Capital Rick Eiswirth - President and Chief Executive Officer Phil Jones - Chief Financial Officer Conference Call Participants Andrew D'Silva - B. Riley Francois Brisebois - Laidlaw Jim Molloy - Alliance Global Partners Yi Chen - H.C. Wainwright Operator Greetings, and welcome to the Alimera Sciences Fourth Quarter and Full Year 2018 Re ...